K., T., S., S., W., S., T., T., P., C., S., T., . . . P., K. (2017). Genetic variation in the Vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study.
استشهاد بنمط شيكاغوK., Thanapirom, et al. Genetic Variation in the Vitamin D Pathway CYP2R1 Gene Predicts Sustained HBeAg Seroconversion in Chronic Hepatitis B Patients Treated With Pegylated Interferon: A Multicenter Study. 2017.
MLA استشهادK., Thanapirom, et al. Genetic Variation in the Vitamin D Pathway CYP2R1 Gene Predicts Sustained HBeAg Seroconversion in Chronic Hepatitis B Patients Treated With Pegylated Interferon: A Multicenter Study. 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.